SG Americas Securities’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,915
| Closed | -$823K | – | 3328 |
|
|
2023
Q2 | $823K | Buy |
+20,915
| New | +$738K | 0.01% | 1162 |
|
|
2023
Q1 | – | Sell |
-239,776
| Closed | -$5.13M | – | 3639 |
|
|
2022
Q4 | $5.13M | Buy |
239,776
+220,173
| +1,123% | +$4.7M | 0.06% | 260 |
|
|
2022
Q3 | $352K | Sell |
19,603
-140,471
| -88% | -$1.84M | ﹤0.01% | 1852 |
|
|
2022
Q2 | $1.54M | Buy |
160,074
+126,444
| +376% | +$1.59M | 0.02% | 923 |
|
|
2022
Q1 | $566K | Sell |
33,630
-2,213
| -6% | -$32.7K | ﹤0.01% | 1808 |
|
|
2021
Q4 | $599K | Sell |
35,843
-25,961
| -42% | -$426K | ﹤0.01% | 2039 |
|
|
2021
Q3 | $1M | Buy |
+61,804
| New | +$673K | ﹤0.01% | 1905 |
|
|
2021
Q2 | – | Sell |
-85,857
| Closed | -$531K | – | 3350 |
|
|
2021
Q1 | $531K | Buy |
85,857
+70,173
| +447% | +$426K | ﹤0.01% | 1990 |
|
|
2020
Q4 | $108K | Buy |
+15,684
| New | +$100K | ﹤0.01% | 2999 |
|
|
2020
Q3 | – | Sell |
-20,783
| Closed | -$106K | – | 3658 |
|
|
2020
Q2 | $106K | Buy |
+20,783
| New | +$86.6K | ﹤0.01% | 3338 |
|
|
2017
Q2 | – | Sell |
-50,867
| Closed | -$186K | – | 3615 |
|
|
2017
Q1 | $186K | Buy |
50,867
+20,537
| +68% | +$86.8K | ﹤0.01% | 2493 |
|
|
2016
Q4 | $146K | Sell |
30,330
-37,487
| -55% | -$1.11M | ﹤0.01% | 2601 |
|
|
2016
Q3 | $3.13M | Buy |
+67,817
| New | +$3.82M | 0.03% | 504 |
|
|
2016
Q2 | – | Sell |
-36,220
| Closed | -$1.53M | – | 3083 |
|
|
2016
Q1 | $1.53M | Buy |
+36,220
| New | +$1.85M | 0.01% | 1034 |
|
|
2015
Q4 | – | Sell |
-3,784
| Closed | -$153K | – | 3054 |
|
|
2015
Q3 | $153K | Buy |
3,784
+748
| +25% | +$39.6K | ﹤0.01% | 1620 |
|
|
2015
Q2 | $158K | Sell |
3,036
-8,600
| -74% | -$428K | ﹤0.01% | 2099 |
|
|
2015
Q1 | $541K | Buy |
11,636
+7,047
| +154% | +$366K | ﹤0.01% | 1422 |
|
|
2014
Q4 | $206K | Buy |
+4,589
| New | +$193K | ﹤0.01% | 2394 |
|
|
2014
Q2 | – | Sell |
-5,852
| Closed | -$209K | – | 2749 |
|
|
2014
Q1 | $209K | Buy |
+5,852
| New | +$197K | ﹤0.01% | 1915 |
|
SG Americas Securities's ISEE Position: Q3 2023 in Review
SG Americas Securities sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 20,915 shares — an estimated $823K sold.
SG Americas Securities first reported a position in ISEE in Q1 2014 and held it in 19 quarters. The position peaked at $5.13M in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- SG Americas Securities reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- SG Americas Securities sold 20,915 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $823K.
- SG Americas Securities first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 19 quarters.
- SG Americas Securities's IVERIC bio, Inc. Common Stock position peaked at $5.13M in Q4 2022.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.